HAVIX CORPORATION
3895・Standard Market・Pulp & Paper
Nonwoven Fabric Business
Habix's core segment manufacturing and selling pulp and synthetic fiber nonwoven fabrics
| Period | Current | Previous | Change |
|---|---|---|---|
| Segment Sales | ¥6,773 million (FY2026, ending March 2026) | ¥7,768 million (FY2025, ended March 2025) | ↓ |
| Segment Profit | ¥1,065 million (FY2026, ending March 2026) | ¥1,318 million (FY2025, ended March 2025) | ↓ |
| Segment Profit Margin | 15.7% (FY2026, ending March 2026) | 17.0% (FY2025, ended March 2025) | ↓ |
| Segment Assets | ¥2,377 million (FY2026, ending March 2026) | ¥2,383 million (FY2025, ended March 2025) | — |
| Depreciation | ¥127 million (FY2026, ending March 2026) | ¥125 million (FY2025, ended March 2025) | — |
| Increase in Property, Plant and Equipment and Intangible Assets | ¥83 million (FY2026, ending March 2026) | ― | — |
Business Details
Manufactures and sells pulp nonwoven fabric (airlaid process) and synthetic fiber nonwoven fabric (thermal bond process). Pulp nonwoven fabric is supplied for cooking paper, drip absorption sheets, and medical/nursing care sanitary products (in-house brand "Kireine"), while synthetic fiber nonwoven fabric is supplied as an intermediate material for surface materials of diapers and pet sheets to major customers. In FY2026 (ending March 2026), net sales were ¥6,773 million, accounting for approximately 55.9% of total company sales of ¥12,110 million, making it the core segment.
Recent Overview
Sales and profit both declined year-on-year due to price revisions and shift to Chinese alternatives
In the Nonwoven Fabric Business for FY2026 (ending March 2026), net sales were ¥6,773 million and segment profit was ¥1,065 million. For both pulp nonwoven fabric and synthetic fiber nonwoven fabric, performance was affected by a decline in orders following price revisions, as well as an ongoing shift toward inexpensive Chinese products and alternative materials. On the other hand, the company continued to expand sales of its medical/nursing care in-house brand "Kireine" and actively pursued sales of synthetic fiber nonwoven fabric for pet sheets and diapers. Additionally, the company announced a manufacturing contract with Unicharm Products Co., Ltd. scheduled to begin in April 2027, and is working to build a new business foundation.
Key Products
Growth Drivers
- Expanding demand for adult diapers amid an aging population and steady growth in the pet sheet market
- Strengthening the processing business through expansion of the product lineup of the medical/nursing care in-house brand "Kireine"
- Securing a new revenue source through the manufacturing contract with Unicharm Products Co., Ltd. scheduled to begin in April 2027
- Continued support for sales volume of commercial cooking paper driven by ongoing growth in inbound demand
- Recovery of profit margins through development of higher value-added products and improved production efficiency
Risks
- Sluggish orders and intensifying price competition due to shift toward inexpensive Chinese products and alternative materials
- Risk of declining orders following price revisions (price increases)
- Rising costs of imported raw materials due to yen depreciation
- Impact of declining birthrate and decreasing demand for Japan-made products in the baby diaper market
- Rising cost-consciousness among consumers due to labor shortages and inflation in the food service industry, and a shift toward lower-priced consumables
- Rising production costs due to soaring raw material and fuel prices amid Middle East tensions
Last updated: June 22, 2026